Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
| Treament | Trials | |||||
|---|---|---|---|---|---|---|
| Demonstrated or suggested benefit | Inconclusive results | Uncertain results | Safety results | |||
| Immunostimulants drugs | inconclusive results for: Emergency room visit or hospitalization; deaths; confirmed COVID (any severity); severe COVID-19 occurrence; serious adverse events; adverse events | suggested 96 % decrease in hospitalization but the degree if certainty is unassessable | - | |||
| anti-inflammatory therapies | none | inconclusive results for: deaths; confirmed COVID (any severity); new illness compatible with Covid-19 | - | - | ||
| Apilimod | 0 | - | - | - | - | |
| corticosteroids | 0 | - | - | - | - | |
| Immunosuppressants drugs | 0 | - | - | - | - | |
| inhaled corticosteroids | 0 | - | - | - | - | |
| Kinase inhibitors | 0 | - | - | - | - | |
| leflunomide | 0 | - | - | - | - | |
| meplazumab | 0 | - | - | - | - | |
| pirfenidone | 0 | - | - | - | - | |
| Polyinosinic-Polycytidylic Acid | 0 | - | - | - | - | |
| sargramostim | 0 | - | - | - | - | |
| statins | 0 | - | - | - | - | |
| thymosin | 0 | - | - | - | - | |
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
